Back to SPPI Stock Lookup
Pages: 1 2 »» Last Page

Spectrum Pharma (SPPI) – Press Releases

Dec 8, 2016 07:00 AM Spectrum Pharmaceuticals Highlights Promising Preclinical Data Evaluating Poziotinib in Lung Cancer at the 17th IASLC World Conference on Lung Cancer
Dec 6, 2016 07:00 AM Spectrum Pharmaceuticals Highlights Survival Advantage in a Case Match Control Analysis of the PROPEL Study with FOLOTYN® (pralatrexate injection) at the 58th Annual Meeting of the American Society
Dec 5, 2016 07:00 AM Spectrum Pharmaceuticals Highlights Five Abstracts on ROLONTIS™ (eflapegrastim) and Poziotinib at the San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas, December 6-10, 2016
Dec 2, 2016 07:00 AM Spectrum Pharmaceuticals Highlights Four Abstracts at the 58th Annual Meeting of the American Society of Hematology (ASH) in San Diego, California, December 3-6, 2016
Nov 17, 2016 07:00 AM Spectrum Pharmaceuticals Announces Poziotinib Data Presentation at the 17th IASLC World Conference on Lung Cancer in Vienna, Austria, December 4-7, 2016
Nov 14, 2016 07:00 AM Spectrum Pharmaceuticals Provides Third Quarter Financial Update
Nov 3, 2016 04:05 PM Spectrum Pharmaceuticals Provides Third Quarter Financial and Pipeline Update
Oct 31, 2016 04:51 PM GPM Reminds Investors of the November 21st Deadline in the Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
Oct 27, 2016 07:00 AM Spectrum Pharmaceuticals Announces Third Quarter 2016 Financial Results Teleconference and Webcast
Oct 19, 2016 03:38 PM Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Spectrum Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm
Oct 18, 2016 07:00 AM Spectrum Pharmaceuticals Announces Appointment of Luigi Lenaz, M.D., as Lead Director
Sep 21, 2016 02:24 PM Glancy Prongay & Murray LLP Commences Investigation on Behalf of Spectrum Pharmaceuticals, Inc. Investors
Sep 21, 2016 07:08 AM Hynes Keller & Hernandez, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI)
Sep 14, 2016 01:06 PM FDA Advisory Committee Votes that Qapzola™ (apaziquone) Has Not Shown Substantial Evidence of a Treatment Effect Over Placebo
Aug 9, 2016 04:00 PM Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results and Pipeline Update
Aug 2, 2016 07:00 AM Spectrum Pharmaceuticals Announces Second Quarter 2016 Financial Results Teleconference and Webcast
Jul 13, 2016 07:00 AM Spectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate injection) ANDA Patent Litigation
Jul 6, 2016 07:00 AM Spectrum Pharmaceuticals to Present Corporate Update at the Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 13th
Jun 1, 2016 07:00 AM Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2016 Healthcare Conference on June 8th
May 6, 2016 07:00 AM Spectrum Pharmaceuticals Highlights an Oral Presentation on Apaziquone at the 2016 Annual Meeting of the American Urological Association Education and Research Inc. (AUA) in San Diego, California, May
May 5, 2016 04:00 PM Spectrum Pharmaceuticals Reports First Quarter 2016 Financial Results and Pipeline Update
May 3, 2016 07:00 AM Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2016 Healthcare Conference on May 10th
Apr 28, 2016 07:00 AM Spectrum Pharmaceuticals Announces First Quarter 2016 Financial Results Teleconference and Webcast
Apr 20, 2016 07:00 AM FDA Grants Orphan Drug Exclusivity to EVOMELA™ (melphalan) for Injection, Indicated for Multiple Myeloma
Mar 15, 2016 09:00 AM Ligand Partner Spectrum Pharmaceuticals Receives FDA Approval of EVOMELA™ (melphalan) for Injection
Mar 15, 2016 07:00 AM FDA Grants Spectrum Pharmaceuticals Approval of EVOMELA™ (melphalan) for Injection
Mar 9, 2016 04:00 PM Spectrum Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial Results and Pipeline Update
Mar 7, 2016 07:00 AM Spectrum Pharmaceuticals Initiates Phase 2 Breast Cancer Trial for Poziotinib, a Novel Pan-HER Inhibitor
Mar 2, 2016 07:00 AM Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2015 Financial Results Teleconference and Webcast
Feb 22, 2016 07:00 AM Spectrum Pharmaceuticals to Present Corporate Update at 2016 RBC Capital Markets' Global Healthcare Conference on February 24
Feb 19, 2016 07:00 AM Spectrum Pharmaceuticals Announces FDA’s Acceptance of NDA Filing for EOquin® (apaziquone for intravesical instillation)
Jan 29, 2016 07:00 AM Spectrum Pharmaceuticals Begins Enrolling Patients in Registrational Trial of SPI-2012, a Novel, Long Acting G-CSF in Patients with Breast Cancer
Jan 11, 2016 07:00 AM Spectrum Pharmaceuticals Signs a Strategic Partnership With Servier Canada
Dec 16, 2015 07:00 AM Spectrum Pharmaceuticals Announces Agreement with FDA on the Special Protocol Assessment (SPA) for the Registrational Trial of SPI-2012, a Novel, Long Acting G-CSF in Patients with Breast Cancer
Dec 15, 2015 01:23 PM TheGrantLawFirm, PLLC Withdraws Action on Behalf of Spectrum Pharmaceuticals, Inc. Purchasers
Dec 10, 2015 08:30 AM Marqibo® Made Available to Acute Lymphoblastic Leukemia Patients Through Global myTomorrows Platform
Dec 9, 2015 07:40 PM INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. and Urges Investors to Contact the Firm
Dec 8, 2015 07:00 AM Spectrum Pharmaceuticals Highlights Four Abstracts on SPI-2012 and Poziotinib at the San Antonio Breast Cancer Symposium (SABCS)
Dec 6, 2015 12:00 PM Spectrum Pharmaceuticals and Onxeo Announce Complete Response in 67% of Patients with Peripheral T-Cell Lymphoma in Combination of Belinostat (Beleodaq®) and Standard CHOP
Dec 4, 2015 07:00 AM Spectrum Pharmaceuticals Highlights 18 Abstracts at the 57th Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, December 5-8, 2015
Nov 20, 2015 07:00 AM Spectrum Pharmaceuticals Submits Phase 2 Breast Cancer Protocol to FDA as Part of an Investigational New Drug (IND) Application for Poziotinib
Nov 18, 2015 03:00 AM Spectrum Pharmaceuticals Divests Rights to ZEVALIN® (ibritumomab tiuxetan) in Japan and Select Other Ex-US Countries to Mundipharma
Nov 17, 2015 12:11 PM TheGrantLawFirm, PLLC Files Class Action on Behalf of Spectrum Pharmaceuticals, Inc. Securities Purchasers
Nov 12, 2015 10:25 PM DEADLINE ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Advises Shareholders to Contact the Firm
Nov 10, 2015 08:14 PM Lifshitz & Miller Law Firm Announces Investigation of Applied DNA Sciences Inc., Barrett Business Services Inc., First Niagara Financial Group, Fidelity & Guaranty Life, SORL Auto Parts, Inc.,
Nov 4, 2015 07:33 PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Strongly Encourages Shareholders to Contact the Firm
Nov 4, 2015 04:02 PM Eagle Pharmaceuticals and Spectrum Pharmaceuticals Announce Co-Promotion Agreement
Nov 4, 2015 04:01 PM Spectrum Pharmaceuticals Reports Third Quarter 2015 Financial Results and Pipeline Update
Nov 4, 2015 10:52 AM TheGrantLawFirm, PLLC Files Class Action on Behalf of Spectrum Pharmaceuticals, Inc. Securities Purchasers
Nov 2, 2015 07:00 AM Spectrum Pharmaceuticals Announces Third Quarter 2015 Financial Results Teleconference and Webcast
Pages: 1 2 »» Last Page

Back to SPPI Stock Lookup